Autologous Anti-CD19 CAR T Cells as Therapy for Systemic Lupus Erythematosus

被引：0
|
作者：
Radic, Marko [1 ]
Randolph, Brion [2 ]
机构：
[1] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN 39163 USA
[2] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 39163 USA
来源：
TRANSPLANTATION AND CELLULAR THERAPY | 2023年 / 29卷 / 01期
关键词：
D O I：
10.1016/j.jtct.2022.12.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] DLBCL Responds Well to Anti-CD19 CAR Therapy
    Rose, Suzanne
    CANCER DISCOVERY, 2017, 7 (03) : 241 - 242
  • [32] Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
    Ambrose, Christine
    Su, Lihe
    Wu, Lan
    Dufort, Fay J.
    Sanford, Thomas
    Birt, Alyssa
    Hackel, Benjamin J.
    Hombach, Andreas
    Abken, Hinrich
    Lobb, Roy R.
    Rennert, Paul D.
    PLOS ONE, 2021, 16 (03):
  • [33] Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL
    Tabbara, Nadeem
    Gaut, Daria
    Oliai, Caspian
    Lewis, Tara
    de Vos, Sven
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [34] Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
    Koh, Seung Kwon
    Kim, Hyojin
    Han, Bohwa
    Jo, Hantae
    Doh, Junsang
    Park, Jeehun
    Ha Nguyen, Minh
    Kim, Hyun-Young
    Kim, Haneul
    Lee, Seung-Hwan
    Kim, Chan Hyuk
    Cho, Duck
    BLOOD, 2025, 145 (09) : 956 - 969
  • [35] CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy
    Guffroy, Aurelien
    Jacquel, Lea
    Guffroy, Blandine
    Martin, Thierry
    JOINT BONE SPINE, 2024, 91 (05)
  • [36] Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
    Garfall, Alfred L.
    Cohen, Adam D.
    Lacey, Simon F.
    Tian, Lifeng
    Hwang, Wei-Ting
    Vogl, Dan T.
    Waxman, Adam
    Lancaster, Eric
    Nelson, Anne Marie
    Ferthio, Regina
    Fesnak, Andrew
    Lamontagne, Anne
    Brennan, Andrea
    Guilliams, Jamie
    Gladney, Whitney Lynn
    Melenhorst, J. Joseph
    Young, Regina M.
    Siegel, Don L.
    Levine, Bruce L.
    Brogdon, Jennifer
    Isaacs, Randi E.
    June, Carl H.
    Milone, Michael C.
    Stadtmauer, Edward A.
    BLOOD, 2019, 134
  • [37] Depletion of Tregs from CD4+ CAR-T cells enhances the tumoricidal effect of CD8+ CAR-T cells in anti-CD19 CAR-T therapy
    Sun, Yunyan
    Liu, Jinyan
    Zhan, Dong
    Wei, Jia
    Li, XianShi
    Zhang, Rui
    Duan, Ci
    Zhang, Disi
    Tang, Xiaorong
    Lin, Tuo
    Li, Limei
    Lai, Xun
    FEBS JOURNAL, 2024,
  • [38] Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas
    Losi, Giulia
    Mussetti, Alberto
    Pena, Marta
    Lopez-Pereira, Patricia
    Sureda, Anna
    Novelli, Silvana
    BONE MARROW TRANSPLANTATION, 2024, : 259 - 269
  • [39] A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy
    Liu Meijing
    Cui, Rui
    Mu, Juan
    Yuan, Ji-Jun
    Mou, Nan
    Yang, Zhen-xing
    Jiang Yan-yu
    Meng Juanxia
    Deng, Qi
    BLOOD, 2019, 134
  • [40] Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
    Arroyo-Rodenas, Javier
    Diez-Alonso, Laura
    Falgas, Aida
    Martinez-Moreno, Alba
    Gil-Etayo, Francisco Javier
    Aguilar-Sopena, Oscar
    Velasco-Sidro, Miriam
    Bravo-Martin, Clara
    Ramirez-Fernandez, Angel
    Jimenez-Reinoso, Anais
    Blanco, Belen
    Roda-Navarro, Pedro
    Bueno, Clara
    Menendez, Pablo
    Alvarez-Vallina, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345